What is the price target for 1HCA stock?
31 analysts have analysed 1HCA.MI and the average price target is 463.93 EUR. This implies a price increase of 7.82% is expected in the next year compared to the current price of 430.3.
BIT:1HCA • US40412C1018
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HCA HEALTHCARE INC (1HCA.MI).
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 64.968B 7.86% | 70.603B 8.67% | 75.6B 7.08% | 79.462B 5.11% | 83.324B 4.86% | 88.119B 5.75% | 93.772B 6.42% | 99.903B 6.54% | 102.844B 2.94% | 107.505B 4.53% | 112.383B 4.54% | |
| EBITDA YoY % growth | 12.704B 5.67% | 13.859B 9.09% | 15.488B 11.75% | 16.184B 4.49% | 16.951B 4.74% | 17.863B 5.38% | 18.959B 6.14% | 20.097B 6.00% | 21.027B 4.63% | 21.981B 4.54% | 22.972B 4.51% | |
| EBIT YoY % growth | 9.627B 6.34% | 10.547B 9.56% | 11.965B 13.44% | 12.462B 4.15% | 13.02B 4.48% | 13.7B 5.22% | 14.765B 7.77% | 15.722B 6.48% | 16.296B 3.65% | 17.035B 4.53% | 17.803B 4.51% | |
| Operating Margin | 14.82% | 14.94% | 15.83% | 15.68% | 15.63% | 15.55% | 15.75% | 15.74% | 15.85% | 15.85% | 15.84% | |
| EPS YoY % growth | 18.66 10.41% | 22.12 18.54% | 28.38 28.30% | 30.66 8.04% | 33.68 9.84% | 37.86 12.42% | 43.67 15.33% | 50.83 16.40% | 60.18 18.39% | 68.64 14.07% | 78.36 14.16% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 7.23 12.07% | 7.54 10.40% | 7.34 5.43% | 8.39 3.13% | 8.06 11.48% | 8.31 10.14% | 8.00 8.96% | 9.37 11.67% | 8.80 9.17% | 9.21 10.85% | 8.30 3.78% | 10.11 7.85% |
| Revenue Q2Q % growth | 19.288B 5.28% | 19.516B 4.90% | 19.964B 4.19% | 20.497B 5.04% | 20.23B 4.88% | 20.456B 4.82% | 20.924B 4.81% | 21.452B 4.66% | 21.166B 4.63% | 21.538B 5.29% | 21.934B 4.83% | 22.752B 6.06% |
| EBITDA Q2Q % growth | 3.907B 5.17% | 4.006B -14.58% | 3.952B -29.14% | 4.259B -36.44% | 4.129B 5.68% | 4.201B 4.87% | 4.127B 4.43% | 4.493B 5.49% | 4.268B 3.37% | 4.449B 5.90% | 4.128B 0.02% | 4.839B 7.70% |
| EBIT Q2Q % growth | 3B 5.08% | 3.082B 3.88% | 3.015B 1.69% | 3.305B 4.00% | 3.191B 6.37% | 3.232B 4.87% | 3.132B 3.88% | 3.487B 5.51% | N/A | N/A | N/A | N/A |
All data in USD
31 analysts have analysed 1HCA.MI and the average price target is 463.93 EUR. This implies a price increase of 7.82% is expected in the next year compared to the current price of 430.3.
HCA HEALTHCARE INC (1HCA.MI) will report earnings on 2026-04-24, before the market open.
The consensus EPS estimate for the next earnings of HCA HEALTHCARE INC (1HCA.MI) is 7.23 EUR and the consensus revenue estimate is 19.29B EUR.
The consensus rating for HCA HEALTHCARE INC (1HCA.MI) is 74.8387 / 100 . This indicates that analysts generally have a positive outlook on the stock.